Institutional Ownership
Titan Pharmaceuticals Inc De
CUSIP 888314705COM NEWTTNPUSDQ1 2026
13D / 13G Filings
2
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
14.1%
Max % of class reported
Institutional Holders
6
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
2 filings · latest Aug 21, 2024
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Corecap Advisors, LLC | 88 | $123 |
| 2 | Global Wealth Strategies & Associates | 2 | $3 |
| 3 | Caldwell Sutter Capital, Inc. | 1 | $1 |
| 4 | St Germain D J Co Inc | 1 | $1 |
| 5 | Bogart Wealth, LLC | 1 | $1 |
| 6 | Farther Finance Advisors, LLC | 1 | $1 |